Preparation and in vivo evaluation of in situ gel system as dual thermo-/pH-responsive nanocarriers for sustained ocular drug delivery

Journal of Microencapsulation

Volumn 32, Issue 5, 2015, Pages 511-519

  Davaran, Soodabeh ^a,b   Lotfipour, Farzaneh ^b   Sedghipour, Naghmeh ^b   Sedghipour, Mohamad Reza ^b   Alimohammadi, Somayeh ^a   Salehi, Roya ^a,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

antimicrobial activity; ciprofloxacin; dual stimuli responsive; In situ nanogel; keratitis; ocular drug delivery

Indexed keywords

CIPROFLOXACIN; NANOCARRIER; NANOPARTICLE; ANTIINFECTIVE AGENT; DRUG CARRIER; GEL; METHACRYLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL KERATITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; EXPERIMENTAL MODEL; FEMALE; GEL; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PH; SUSTAINED OCULAR DRUG DELIVERY; TEMPERATURE; CHEMISTRY; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; KERATITIS; PHARMACOKINETICS; PHARMACOLOGY;

ADMINISTRATION, OPHTHALMIC; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG CARRIERS; GELS; HUMANS; KERATITIS; METHACRYLATES; NANOPARTICLES; PARTICLE SIZE;

EID: 84938857123     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2015.1065915     Document Type: Article

References (57)

1. Abelson MB, Udell IJ, Weston JH. Normal human tear pH by direct measurement. Arch Ophtalmol, 1981; 99: 301
2. Agrawal AK, Das M, Jain S. In situ gel systems as smart'carriers for sustained ocular drug delivery. Expert Opin Drug Deliv, 2012; 9: 383-402
3. Calvo P, Vila-Jato JL, Alonso MJ. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J Pharm Sci, 1996; 85: 530-6
4. Chandasana H, Prasad YD, Chhonker YS, Chaitanya TK, Mishra NN, Mitra K, Shukla PK, Bhatta RS. Corneal targeted nanoparticles for sustained natamycin delivery and their PK/PD indices: An approach to reduce dose and dosing frequency. Int J Pharm, 2014; 477: 317-25
5. Dhakwa K, Sharma M, Bajimaya S, Dwivedi A, Rai SK. Causative organisms in microbial keratitis, their sensitivity pattern and treatment outcome in western Nepal. Nepal J Ophthalmol, 2012; 4: 119-27
6. Dilbaghi N, Kaur H, Ahuja M, Kumar S. Evaluation of tropicamide-loaded tamarind seed xyloglucan nanoaggregates for ophthalmic delivery. Carbohydr Polym, 2013; 94: 286-91
7. Ebrahim S, Peyman GA, Lee PJ. Applications of liposomes in ophthalmology. Surv Ophthalmol, 2005; 50: 167-82
8. Gao Y, Sun Y, Ren F, Gao S. PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate. Drug Dev Ind Pharm, 2010; 36: 1131-8
9. Gupta AK, Madan S, Majumdar D, Maitra A. Ketorolac entrapped in polymeric micelles: Preparation, characterisation and ocular anti-inflammatory studies. Int J Pharm, 2000; 209: 1-14
10. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine, 2010; 6: 324-33
11. Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv, 2007; 14: 507-15
12. Gurny R, Ibrahim H, Buri P. 1993. The development and use of in situ formed gels, triggered by pH. In: Edman P., ed. Biopharmaceutics of ocular drug delivery. Boca Raton, FL: CRC Press, pp. 81-90
13. Hajoui F-Z, Daoudi N, Kabbaj H, Alaoui A, Seffar M. Bacteriological study of the strains isolated from ocular infections. Ann Biol Clin, 2011; 70: 689-94
14. Hatefi A, Amsden B. Biodegradable injectable in situ forming drug delivery systems. J Control Release, 2002; 80: 9-28
15. He E, Yue C, Tam K. Binding and release studies of a cationic drug from a star-shaped four-arm poly (ethylene oxide)-b-poly (methacrylic acid). J Pharm Sci, 2010; 99: 782-93
16. Hsiue GH, Hsu SH, Yang CC, Lee SH, Yang IK. Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. Biomaterials, 2002; 23: 457-62
17. Jain RL, Shastri J. Study of ocular drug delivery system using drug-loaded liposomes. Int J Pharm Investig, 2011; 1: 35-41
18. Gokul KC, Gurung DB, Adhikary PR. Modeling airflow effects in human eye temperature with and wothout eyelids. Int J Appl Math Mech, 2014; 10: 82-98
19. Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm, 2002; 28: 353-69
20. Kawasaki S, Mizoue S, Yamaguchi M, Shiraishi A, Zheng X, Hayashi Y, Ohashi Y. Evaluation of filtering bleb function by thermography. Br J Ophthalmol, 2009; 93: 1331-6
21. Kessel L, Johnson L, Arvidsson HS, Larsen M. Corneal temperature is related to both body temperature and ambient temperature. Invest Ophthalmol Vis Sci, 2010; 51: 6593-7
22. Khurana V, P Patel S, Agrahari V, Pal D, Mitra AK. Novel pentablock copolymer based nanoparticles containing pazopanib: A potential therapy for ocular neovascularization. Recent Pat Nanomed, 2014; 4: 57-68
23. Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol, 2004; 138: 33-7
24. Law S, Huang K, Chiang C. Acyclovir-containing liposomes for potential ocular delivery: Corneal penetration and absorption. J Control Release, 2000; 63: 135-40
25. Lv F-F, Zheng L-Q, Tung C-H. Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. Int J Pharm, 2005; 301: 237-46
26. Mannis MJ. The use of antimicrobial peptides in ophthalmology: An experimental study in corneal preservation and the management of bacterial keratitis. Trans Am Ophthalmol Soc, 2002; 100: 243
27. Mapstone R. Measurement of corneal temperature. Exp Eye Res, 1968; 7: 237-43
28. Marquart ME. Animal models of bacterial keratitis. J Biomed Biotechnol, 2011; 2011: 680642
29. Meister U, Ohnesorge B, Körner D, Boevé MH. Evaluation of ultrasound velocity in enucleated equine aqueous humor, lens and vitreous body. BMC Vet Res, 2014; 10: 250
30. Mortazavi SA, Jaffariazar Z, Damercheli E. Formulation and in-vitro evaluation of ocular ciprofloxacin-containing minitablets prepared with different combinations of carbopol 974P and various cellulose derivatives. Iran J Pharm Res, 2010; 9: 107-14
31. Mouly S, Mahé I, Haouchine B, Sanson-Le-Pors MJ, Blain P, Tillet Y, Dewailly J, Mongold JJ, Bergmann JF. Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: Potential alternative as drug delivery system prior to cataract surgery. Basic Clin Pharmacol Toxicol, 2006; 98: 547-54
32. Mundada A, Shrikhande B. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm, 2006; 32: 443-8
33. Ng E, Ooi EH. FEM simulation of the eye structure with bioheat analysis. Comput Methods Programs Biomed, 2006; 82: 268-76
34. Packhaeuser C, Schnieders J, Oster C, Kissel T. In situ forming parenteral drug delivery systems: An overview. Eur J Pharm Biopharm, 2004; 58: 445-55
35. Pawar P, Kashyap H, Malhotra S, Sindhu R. Hp-β-CD-Voriconazole in situ gelling system for ocular drug delivery: In vitro, stability, and antifungal activities assessment. Biomed Res Int, 2013; 2013: 341218
36. Pawar S, Gadhave M, Jadhav S, Gaikwad D. Research article: Design and evaluation of polymeric ocular drug delivery system for controlled delivery of ciprofloxacin hydrochloride. J Drug Deliv Ther 2011; 2: 49-52
37. Prokosch V, Gatzioufas Z, Thanos S, Stupp T. Microbiological findings and predisposing risk factors in corneal ulcers. Graefes Arch Clin Exp Ophthalmol, 2012; 250: 369-74
38. Purslow C, Wolffsohn J. The relation between physical properties of the anterior eye and ocular surface temperature. Optom Vis Sci, 2007; 84: 197-201
39. Purslow C, Wolffsohn JS. Ocular surface temperature: A review. Eye Contact Lens, 2005; 31: 117-23
40. Purslow C, Wolffsohn JS, Santodomingo-Rubido J. The effect of contact lens wear on dynamic ocular surface temperature. Cont Lens Anterior Eye, 2005; 28: 29-36
41. Rafie F, Javadzadeh Y, Javadzadeh AR, Ghavidel LA, Jafari B, Moogooee M, Davaran S. In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye. Curr Eye Res 2010; 35: 1081-9
42. Rasouli S, Davaran S, Rasouli F, Mahkam M, Salehi R. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery. Drug Deliv, 2014; 21: 155-63
43. Rawas-Qalaji M, Williams C-A. Advances in ocular drug delivery. Curr Eye Res, 2012; 37: 345-56
44. Refai H, Tag R. Development and characterization of sponge-like acyclovir ocular minitablets. Drug Deliv, 2011; 18: 38-45
45. Salehi R, Arsalani N, Davaran S, Entezami A. Synthesis and characterization of thermosensitive and pH-sensitive poly (N-isopropylacrylamide-acrylamide-vinylpyrrolidone) for use in controlled release of naltrexone. J Biomed Mater Res A, 2009a; 89: 919-28
46. Salehi R, Irani M, Eskandani M, Nowruzi K, Davaran S, Haririan I. Interaction, controlled release, and antitumor activity of doxorubicin hydrochloride from pH-sensitive P (NIPAAm-MAA-VP) nanofibrous scaffolds prepared by green electrospinning. Int J Polym Mater Polym Biomater, 2014; 63: 609-19
47. Salehi R, Nowruzi K, Entezami A, Asgharzadeh V, Davaran S. Thermosensitive polylactide-glycolide delivery systems for treatment of narcotic addictions. Polym Adv Technol, 2009b; 20: 416-22
48. Salehi R, Nowruzi K, Salehi S, Khandaghi AA, Davaran S, Entezami AA. Smart poly (Nisopropylacrylamide)-block-poly (L-Lactide) nanoparticles for prolonged release of Naltrexone. Int J Polym Mater Polym Biomater, 2013; 62: 686-94
49. Shalchi Z, Gurbaxani A, Baker M, Nash J. Antibiotic resistance in microbial keratitis: Ten-year experience of corneal scrapes in the United Kingdom. Ophthalmology, 2011; 118: 2161-5
50. Stapleton F, Edwards K, Keay L, Naduvilath T, Dart JK, Brian G, Holden B. Risk factors for moderate and severe microbial keratitis in daily wear contact lens users. Ophthalmology, 2012; 119: 1516-21
51. Stapleton F, Keay L, Edwards K, Naduvilath T, Brian G, Jacobs R. Studies of contact lens-related microbial keratitis in australia and New Zealand: New learnings. Eye Contact Lens, 2007; 33: 354-7
52. Torniainen K, Tammilehto S, Ulvi V. The effect of pH, buffer type and drug concentration on the photodegradation of ciprofloxacin. Int J Pharm, 1996; 132: 53-61
53. Üstündaʇ-Okur N, Gökçe EH, Bozbyk DI, Eʇrilmez S, Özer Ö, Ertan G. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Eur J Pharm Sci, 2014; 63: 204-15
54. Vadlapudi D, Mitra A. Sustained delivery of biologics to back of the eye. J Biotechnol Biomater, 2013; 3: e122
55. Weyenberg W, Vermeire A, Dhondt MM, Adriaens E, Kestelyn P, Remon JP, Ludwig A. Ocular bioerodible minitablets as strategy for the management of microbial keratitis. Invest Ophthalmol Vis Sci, 2004; 45: 3229-33
56. Wu XG, Xin M, Chen H, Yang LN, Jiang HR. Novel mucoadhesive polysaccharide isolated from Bletilla striata improves the intraocular penetration and efficacy of levofloxacin in the topical treatment of experimental bacterial keratitis. J Pharm Pharmcol, 2010; 62: 1152-7
57. Zhang L, Pornpattananangkul D, Hu C-M, Huang C-M. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 2010; 17: 585-94